Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Gadobenate-dimeglumine-enhanced magnetic resonance imaging for hepatic lesions in children.

Chavhan GB, Mann E, Kamath BM, Babyn PS.

Pediatr Radiol. 2014 Apr 27. [Epub ahead of print]

PMID:
24771094
[PubMed - as supplied by publisher]
2.

MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.

Grazioli L, Morana G, Kirchin MA, Caccia P, Romanini L, Bondioni MP, Procacci C, Chiesa A.

J Magn Reson Imaging. 2003 May;17(5):593-602.

PMID:
12720270
[PubMed - indexed for MEDLINE]
3.

Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.

Grazioli L, Morana G, Kirchin MA, Schneider G.

Radiology. 2005 Jul;236(1):166-77. Epub 2005 Jun 13.

PMID:
15955857
[PubMed - indexed for MEDLINE]
4.

Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.

Kim HJ, Kim BS, Kim MJ, Kim SH, de Campos RO, Hernandes M, Semelka RC.

J Magn Reson Imaging. 2013 Apr;37(4):903-8. doi: 10.1002/jmri.23874. Epub 2012 Oct 12.

PMID:
23065959
[PubMed - indexed for MEDLINE]
5.

Focal nodular hyperplasia: intraindividual comparison of dynamic gadobenate dimeglumine- and ferucarbotran-enhanced magnetic resonance imaging.

Marin D, Iannaccone R, Laghi A, Catalano C, Murakami T, Hori M, Kim T, Passariello R.

J Magn Reson Imaging. 2007 Apr;25(4):775-82.

PMID:
17348002
[PubMed - indexed for MEDLINE]
6.

Gadobenate dimeglumine-enhanced liver magnetic resonance imaging: value of hepatobiliary phase for the detection of focal liver lesions.

Fu GL, Du Y, Zee CS, Yang HF, Li Y, Duan RG, Zeng NL, Xiao DM.

J Comput Assist Tomogr. 2012 Jan-Feb;36(1):14-9. doi: 10.1097/RCT.0b013e31823dc139.

PMID:
22261765
[PubMed - indexed for MEDLINE]
7.

Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.

Gupta RT, Iseman CM, Leyendecker JR, Shyknevsky I, Merkle EM, Taouli B.

AJR Am J Roentgenol. 2012 Jul;199(1):35-43. doi: 10.2214/AJR.11.7757.

PMID:
22733891
[PubMed - indexed for MEDLINE]
8.

Metastasis versus focal eosinophilic infiltration of the liver in patients with extrahepatic abdominal cancer: an evaluation with gadobenate dimeglumine-enhanced magnetic resonance imaging.

Park MS, Kim MJ, Lim JS, Kim SH, Kim HS, Chung YE, Kim KW.

J Comput Assist Tomogr. 2009 Jan-Feb;33(1):119-24. doi: 10.1097/RCT.0b013e3181641b1a.

PMID:
19188798
[PubMed - indexed for MEDLINE]
9.

Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine.

Grazioli L, Morana G, Federle MP, Brancatelli G, Testoni M, Kirchin MA, Menni K, Olivetti L, Nicoli N, Procacci C.

Radiology. 2001 Dec;221(3):731-9.

PMID:
11719669
[PubMed - indexed for MEDLINE]
10.

Hypointense hepatic lesions depicted on gadobenate dimeglumine-enhanced three-hour delayed hepatobiliary-phase MR imaging: differentiation between benignancy and malignancy.

Hwang HS, Kim SH, Jeon TY, Choi D, Lee WJ, Lim HK.

Korean J Radiol. 2009 May-Jun;10(3):294-302. doi: 10.3348/kjr.2009.10.3.294. Epub 2009 Apr 22. Review.

PMID:
19412518
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI.

Choi SH, Lee JM, Yu NC, Suh KS, Jang JJ, Kim SH, Choi BI.

AJR Am J Roentgenol. 2008 Aug;191(2):529-36. doi: 10.2214/AJR.07.2565.

PMID:
18647927
[PubMed - indexed for MEDLINE]
12.

[Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].

Di Cesare E, Cariello G, Barile A, Sabatini M, Michelini O, Erriquez D, Masciocchi C.

Radiol Med. 2000 Oct;100(4):245-50. Italian.

PMID:
11155451
[PubMed - indexed for MEDLINE]
13.

Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.

Kim JY, Lee SS, Byun JH, Kim SY, Park SH, Shin YM, Lee MG.

AJR Am J Roentgenol. 2013 Aug;201(2):322-31. doi: 10.2214/AJR.12.9478.

PMID:
23883212
[PubMed - indexed for MEDLINE]
14.

Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.

Quaia E, Pizzolato R, De Paoli L, Angileri R, Ukmar M, Cova MA.

J Magn Reson Imaging. 2013 Apr;37(4):892-902. doi: 10.1002/jmri.23873. Epub 2012 Oct 23.

PMID:
23097278
[PubMed - indexed for MEDLINE]
15.

Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI.

Mortelé KJ, Praet M, Van Vlierberghe H, de Hemptinne B, Zou K, Ros PR.

Abdom Imaging. 2002 Nov-Dec;27(6):700-7.

PMID:
12395259
[PubMed - indexed for MEDLINE]
16.

Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.

Suh YJ, Kim MJ, Choi JY, Park YN, Park MS, Kim KW.

AJR Am J Roentgenol. 2011 Jul;197(1):W44-52. doi: 10.2214/AJR.10.5845.

PMID:
21700994
[PubMed - indexed for MEDLINE]
17.

Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual crossover comparison.

Schneider G, Maas R, Schultze Kool L, Rummeny E, Gehl HB, Lodemann KP, Kirchin MA.

Invest Radiol. 2003 Feb;38(2):85-94.

PMID:
12544071
[PubMed - indexed for MEDLINE]
18.

Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.

Schneider G, Altmeyer K, Kirchin MA, Seidel R, Grazioli L, Morana G, Saini S.

Invest Radiol. 2007 Feb;42(2):105-15.

PMID:
17220728
[PubMed - indexed for MEDLINE]
19.

Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions.

Pirovano G, Vanzulli A, Marti-Bonmati L, Grazioli L, Manfredi R, Greco A, Holzknecht N, Daldrup-Link HE, Rummeny E, Hamm B, Arneson V, Imperatori L, Kirchin MA, Spinazzi A.

AJR Am J Roentgenol. 2000 Oct;175(4):1111-20.

PMID:
11000175
[PubMed - indexed for MEDLINE]
20.

Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial.

Peña CS, Saini S, Baron RL, Hamm BA, Morana G, Caudana R, Giovagnoni A, Villa A, Carriero A, Mathieu D, Bourne MW, Kirchin MA, Pirovano G, Spinazzi A.

Korean J Radiol. 2001 Oct-Dec;2(4):210-5.

PMID:
11754328
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk